Akums Drugs and Pharmaceuticals announces robust Q3 FY 25 results with 12% Adj EBITDA and 15% Adj PAT growth

Feb 08, 2025

New Delhi [India], February 8: Akums Drugs and Pharmaceuticals Ltd., has announced its consolidated financial results for the quarter ended December 31, 2024, delivering...

Akums Reports Q1 FY26 with 19% YoY Adj EBITDA Growth; Achieves 1,000 DCGI Approvals

Aug 09, 2025

New Delhi [India], August 9: Akums Drugs and Pharmaceuticals Ltd., India's largest contract development and manufacturing organization (CDMO), has announced its consolidated financial results...

Patel Retail Limited Posts Strong Q2 FY26 Performance with 15% Revenue Growth, 31% EBITDA Growth, & an Impressive 73% PAT Surge

Dec 06, 2025

Mumbai (Maharashtra) [India], December 6: Patel Retail Limited (BSE: 544487 | NSE: PATELRMART), a diversified retail and food processing company, announced its Unaudited Financial...

Tata Power registers record profit and EBITDA surge in Q3 FY24

Feb 09, 2024

According to a press release by Tata, the company reported a Profit After Tax (PAT) of Rs 1,076 crore, marking a significant growth trajectory...

Akums Reports Q4 FY25 with 12.4% Revenue Growth, FY25 Adj. EBITDA Remained Strong at 12.3%

May 27, 2025

New Delhi [India], May 27: Akums Drugs and Pharmaceuticals Ltd., India's largest contract development and manufacturing organization (CDMO), has announced its consolidated financial results...

EaseMyTrip soars with Q2-FY24 results and strategic expansions

Nov 09, 2023

The company reported a Profit After Tax (PAT) of RS 47.2 crores, showcasing a YoY growth of 67.2 per cent.